Debunking Cannabidiol as a Treatment for COVID-19: Time for the FDA to Adopt a Focused Deterrence Model?

Many cannabidiol (CBD) retailers make unsupported medical claims about their product. In recent years, the U.S. Food and Drug Administration (FDA) has sent warning letters to CBD retailers who promoted CBD to treat Alzheimer’s disease, cancer, diabetes, and other serious conditions for which there i...

Descripción completa

Detalles Bibliográficos
Autores principales: Shover, Chelsea L, Humphreys, Keith
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2020
Materias:
Infectious Disease
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7370674/
https://www.ncbi.nlm.nih.gov/pubmed/32699671
http://dx.doi.org/10.7759/cureus.8671

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7370674/
https://www.ncbi.nlm.nih.gov/pubmed/32699671
http://dx.doi.org/10.7759/cureus.8671

Ejemplares similares